Session » Epidemiology & Public Health Poster II: OA, Osteoporosis, & Other Rheumatic Disease

Date: Saturday, November 7, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM: Abstract Number: 0538

Autoimmune Disease Outcomes of Women with Breast Implants: A Population-Based Study

9:00AM-11:00AM: Abstract Number: 0533

Characterization of Older Male Patients with a Fragility Fracture

9:00AM-11:00AM: Abstract Number: 0549

Developing an Algorithm for Identifying Mortality in MarketScan Claims Data Using Machine Learning

9:00AM-11:00AM: Abstract Number: 0542

Examining the Long-Term and Short-Term Day-To-Day Pain Variability in Inflammatory and Non-Inflammatory Rheumatic and Musculoskeletal Diseases Using Multilevel and Markov Transition Models: Cloudy with a Chance of Pain, a National U.K. Smartphone Study

9:00AM-11:00AM: Abstract Number: 0543

Exercise Among Older Adults Living with Rheumatic Disease: Physical Activity Habits and Patient Reported Outcomes

9:00AM-11:00AM: Abstract Number: 0552

Fast Food Habits and Serum Urate Change in Young Adults: 15-Year Prospective Cohort Analysis

9:00AM-11:00AM: Abstract Number: 0566

Healthcare Utilization and Costs Prior to Diagnosis of ANCA Vasculitis in Medicare Beneficiaries

9:00AM-11:00AM: Abstract Number: 0537

Hip Abductor Strength and Its Association with New or Worsening Knee Pain: The MOST Study

9:00AM-11:00AM: Abstract Number: 0565

In Those with Unilateral Frequent Knee Pain, Between-Limb Differences in Stance Time During Walking Increase the Risk of Frequent Pain in the Other Knee: The MOST Study

9:00AM-11:00AM: Abstract Number: 0564

Incidence and Progression of Foot Osteoarthritis

9:00AM-11:00AM: Abstract Number: 0548

Incidence of First Cardiovascular Event in Spanish Patients with Chronic Inflammatory Rheumatic Diseases. Prospective Data After Five Years of Follow Up

9:00AM-11:00AM: Abstract Number: 0554

Increased Burden of Painful Arthritis and Rheumatism Following the Chikungunya Epidemic 2006: India Rural Population Survey 2018

9:00AM-11:00AM: Abstract Number: 0559

Low Frequency of ANA/DFS70 Pattern Positive Result in a Large Cohort of Autoimmune/autoinflammatory Diseases Compared with First Degree Relatives and Healthy Controls Evaluated in a Single Hospital from Colombia

9:00AM-11:00AM: Abstract Number: 0550

Mapping Multimorbidity Using Drug Concept Unique Identifiers (RxCUIs) via the Rx-Risk Comorbidity Index

9:00AM-11:00AM: Abstract Number: 0560

Mortality Burden of Immune-Mediated Inflammatory Diseases (IMID): Race/Ethnicity, Sex, and Geographic Variation in the United States

9:00AM-11:00AM: Abstract Number: 0534

National Variation and Factors Associated with Long-term Opioid Use for Non-cancer Pain in the First Year of Use

9:00AM-11:00AM: Abstract Number: 0551

Physical Performance as a Mediator of the Association Between Depression and Pain in Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 0535

Provider Opinion and Support for Shared Decision-making in Gout Treatment: A Quality Improvement National Survey of Veterans Affairs Rheumatologists

9:00AM-11:00AM: Abstract Number: 0556

Recent Use, Missed Doses and Discontinuation of Infliximab in New-users: Comparisons of Biosimilar and Originator Exposures

9:00AM-11:00AM: Abstract Number: 0563

Relation of Pain Sensitization to Isokinetic Knee Extension Torque: The MOST Study

9:00AM-11:00AM: Abstract Number: 0561

Risk Factors for Falls Among Individuals with Knee OA: A Longitudinal Community-based Study

9:00AM-11:00AM: Abstract Number: 0544

Risk Factors for Lumbar Vertebral Osteoporosis Do Not Reflect Factors Traditionally Associated with Osteoporosis at the Hip

9:00AM-11:00AM: Abstract Number: 0540

Risk of Hydroxychloroquine Retinopathy in the Community

9:00AM-11:00AM: Abstract Number: 0539

Sports with a Bat or Racket Are Not Associated with Thumb-base Osteoarthritis: Data from the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 0532

State-Specific Percentage of Adults with Arthritis Who Report Both Severe Joint Pain and Physical Inactivity and Their Characteristics, United States, Behavioral Risk Factor Surveillance System, 2017

9:00AM-11:00AM: Abstract Number: 0558

Statin Use Pattern in Patients with Inflammatory Joint Disease in a Single Site VA Medical Center

9:00AM-11:00AM: Abstract Number: 0546

Stepping up for Inflammatory Arthritis (SUFIA): A Pilot Trial to Test Behavioral Economics Strategy to Increase Physical Activity in Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 0541

Suboptimal Vaccination Coverage with Influenza, Pneumococcal and Herpes Zoster Vaccines Among Adult Patients with Autoimmune Inflammatory Rheumatic Diseases in a Nationwide Health Care Plan

9:00AM-11:00AM: Abstract Number: 0536

Systematic Geriatric Assessment in Older Patients with Rheumatic Diseases – The RheuMAGIC Pilot Study

9:00AM-11:00AM: Abstract Number: 0557

The Joint Association of Steps/day and Typical Sedentary Bout Length with Worsening Knee Cartilage Damage over Two Years: The MOST Study

9:00AM-11:00AM: Abstract Number: 0531

The Prevalence of Systemic Sclerosis, Dermatomyositis/Polymyositis, and Giant Cell Arteritis in the United States by Race and Ethnicity: An Analysis Using Electronic Health Records

9:00AM-11:00AM: Abstract Number: 0562

The Relationship Between Heart Disease Risk Profile and Osteoarthritis, Overall and by Multi-/Single-Joint Involvement

9:00AM-11:00AM: Abstract Number: 0553

The US Prevalence of Ulcerative Colitis Associated Peripheral Arthralgias and Arthritis: Data from the National Health & Nutrition Examination Survey (NHANES)

9:00AM-11:00AM: Abstract Number: 0545

The Use of Tocilizumab and Tofacitinib in Patients with Resolved Hepatitis B Infection: A Case Series

9:00AM-11:00AM: Abstract Number: 0547

Transgender Patients in the Rheumatology Setting

9:00AM-11:00AM: Abstract Number: 0555

Utilization and Adherence Among Infliximab Biosimilar Initiators in a U.S. National Commercial Insurance Database

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].